Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-EN Version v4-FR
Language English French
Date Updated 2018-05-19 2017-04-04
Drug Identification Number 02231459 02231459
Brand name MAVIK MAVIK
Common or Proper name Trandolapril Trandolapril
Company Name BGP PHARMA ULC BGP PHARMA ULC
Ingredients TRANDOLAPRIL TRANDOLAPRIL
Strength(s) 1MG 1MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL
Packaging size 100 100
ATC code C09AA C09AA
ATC description ACE INHIBITORS, PLAIN ACE INHIBITORS, PLAIN
Reason for shortage Requirements related to complying with good manufacturing practices. Requirements related to complying with good manufacturing practices.
Anticipated start date 2018-05-17
Actual start date 2018-05-18 2017-02-17
Estimated end date 2018-05-31
Actual end date 2017-04-03
Shortage status Actual shortage Resolved
Tier 3 Status No No
Company comments
Health Canada comments